Rajeev Saggar Sells 2,526 Shares of Liquidia Technologies, Inc. (NASDAQ:LQDA) Stock

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Rajeev Saggar sold 2,526 shares of the firm's stock in a transaction on Monday, July 21st. The stock was sold at an average price of $14.54, for a total transaction of $36,728.04. Following the completion of the sale, the insider owned 268,887 shares of the company's stock, valued at $3,909,616.98. This trade represents a 0.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Rajeev Saggar also recently made the following trade(s):

• On Monday, July 14th, Rajeev Saggar sold 5,327 shares of Liquidia Technologies stock. The stock was sold at an average price of $14.28, for a total transaction of $76,069.56.

Liquidia Technologies Stock Performance

Shares of Liquidia Technologies stock traded up $0.83 during trading on Friday, hitting $19.60. 3,766,147 shares of the stock were exchanged, compared to its average volume of 2,263,899. The stock's fifty day moving average is $14.85 and its 200 day moving average is $14.70. The stock has a market cap of $1.68 billion, a PE ratio of -12.40 and a beta of -0.01. The company has a debt-to-equity ratio of 2.08, a quick ratio of 2.91 and a current ratio of 2.93. Liquidia Technologies, Inc. has a 12 month low of $8.26 and a 12 month high of $19.76.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The company had revenue of $3.12 million during the quarter, compared to analyst estimates of $3.23 million. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. As a group, sell-side analysts anticipate that Liquidia Technologies, Inc. will post -1.51 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Wall Street Zen upgraded shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Oppenheimer set a $13.00 price target on shares of Liquidia Technologies and gave the stock an "underperform" rating in a report on Monday, May 19th. Needham & Company LLC reiterated a "buy" rating on shares of Liquidia Technologies in a report on Monday, June 2nd. Raymond James Financial lifted their price target on shares of Liquidia Technologies from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a report on Friday, May 9th. Finally, Wells Fargo & Company lifted their price target on shares of Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a report on Thursday, June 12th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $26.89.

Institutional Trading of Liquidia Technologies

Hedge funds have recently bought and sold shares of the company. Corebridge Financial Inc. increased its holdings in shares of Liquidia Technologies by 2.3% in the 4th quarter. Corebridge Financial Inc. now owns 31,516 shares of the company's stock valued at $371,000 after purchasing an additional 694 shares during the period. Ballentine Partners LLC increased its holdings in shares of Liquidia Technologies by 10.2% in the 2nd quarter. Ballentine Partners LLC now owns 12,139 shares of the company's stock valued at $151,000 after purchasing an additional 1,119 shares during the period. GAMMA Investing LLC increased its holdings in shares of Liquidia Technologies by 65.6% in the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares during the period. Cetera Investment Advisers increased its holdings in shares of Liquidia Technologies by 4.3% in the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock valued at $367,000 after purchasing an additional 1,277 shares during the period. Finally, Valmark Advisers Inc. increased its holdings in shares of Liquidia Technologies by 7.4% in the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company's stock valued at $275,000 after purchasing an additional 1,283 shares during the period. 64.54% of the stock is owned by hedge funds and other institutional investors.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).